Onyx Healthcare Inc. (TPEX:6569)
Taiwan
· Delayed Price · Currency is TWD 96.10
+2.20 (2.34%)
At close: Mar 6, 2026
Onyx Healthcare Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 1,313 | 1,241 | 1,493 | 1,600 | 1,202 | Upgrade
|
| Revenue Growth (YoY) | 5.80% | -16.85% | -6.71% | 33.16% | -10.80% | Upgrade
|
| Cost of Revenue | 879.27 | 784.98 | 936.72 | 1,128 | 838.03 | Upgrade
|
| Gross Profit | 434.02 | 456.28 | 556.14 | 472.31 | 363.73 | Upgrade
|
| Selling, General & Admin | 271.23 | 247.47 | 258.98 | 241.59 | 208.96 | Upgrade
|
| Research & Development | 112.49 | 118.32 | 79.36 | 86.67 | 79.35 | Upgrade
|
| Operating Expenses | 381.77 | 367.55 | 338.02 | 326.91 | 289.22 | Upgrade
|
| Operating Income | 52.24 | 88.73 | 218.12 | 145.39 | 74.51 | Upgrade
|
| Interest Expense | -4.68 | -4.36 | -3.68 | -3.56 | -2.63 | Upgrade
|
| Interest & Investment Income | 2.41 | 13.88 | 3.39 | 4.69 | 6.36 | Upgrade
|
| Earnings From Equity Investments | 68.51 | 67.1 | 62.87 | 62.94 | 50.19 | Upgrade
|
| Currency Exchange Gain (Loss) | - | 13.12 | -7.42 | 19.28 | -6.02 | Upgrade
|
| Other Non Operating Income (Expenses) | 3.42 | 18 | 19.85 | 25.41 | 18.57 | Upgrade
|
| EBT Excluding Unusual Items | 121.91 | 196.47 | 293.14 | 254.14 | 140.98 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | 9.95 | 11.86 | -12.45 | -0.87 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | 0.25 | - | Upgrade
|
| Other Unusual Items | - | -0.01 | 0.01 | 0.09 | -0.01 | Upgrade
|
| Pretax Income | 121.91 | 206.41 | 305 | 242.03 | 140.11 | Upgrade
|
| Income Tax Expense | 10.21 | 26.28 | 49.83 | 38.9 | 13.6 | Upgrade
|
| Earnings From Continuing Operations | 111.7 | 180.13 | 255.17 | 203.14 | 126.51 | Upgrade
|
| Minority Interest in Earnings | 0.43 | 0.79 | 0.09 | -0.18 | 1.04 | Upgrade
|
| Net Income | 112.13 | 180.91 | 255.26 | 202.96 | 127.55 | Upgrade
|
| Net Income to Common | 112.13 | 180.91 | 255.26 | 202.96 | 127.55 | Upgrade
|
| Net Income Growth | -38.02% | -29.13% | 25.77% | 59.12% | -23.66% | Upgrade
|
| Shares Outstanding (Basic) | 39 | 39 | 38 | 37 | 35 | Upgrade
|
| Shares Outstanding (Diluted) | 39 | 39 | 39 | 38 | 35 | Upgrade
|
| Shares Change (YoY) | 0.35% | 0.61% | 2.85% | 7.68% | -0.14% | Upgrade
|
| EPS (Basic) | 2.88 | 4.69 | 6.66 | 5.43 | 3.67 | Upgrade
|
| EPS (Diluted) | 2.87 | 4.65 | 6.60 | 5.39 | 3.65 | Upgrade
|
| EPS Growth | -38.28% | -29.54% | 22.41% | 47.62% | -23.50% | Upgrade
|
| Free Cash Flow | 147.49 | 117.53 | 282.91 | 149.84 | -277.64 | Upgrade
|
| Free Cash Flow Per Share | 3.77 | 3.02 | 7.31 | 3.98 | -7.95 | Upgrade
|
| Dividend Per Share | - | 4.000 | 4.348 | 4.348 | 3.479 | Upgrade
|
| Dividend Growth | - | -8.01% | - | 25.00% | -20.00% | Upgrade
|
| Gross Margin | 33.05% | 36.76% | 37.25% | 29.51% | 30.27% | Upgrade
|
| Operating Margin | 3.98% | 7.15% | 14.61% | 9.09% | 6.20% | Upgrade
|
| Profit Margin | 8.54% | 14.57% | 17.10% | 12.68% | 10.61% | Upgrade
|
| Free Cash Flow Margin | 11.23% | 9.47% | 18.95% | 9.36% | -23.10% | Upgrade
|
| EBITDA | 74.05 | 105.12 | 235.93 | 163.63 | 90.84 | Upgrade
|
| EBITDA Margin | 5.64% | 8.47% | 15.80% | 10.22% | 7.56% | Upgrade
|
| D&A For EBITDA | 21.81 | 16.4 | 17.81 | 18.24 | 16.33 | Upgrade
|
| EBIT | 52.24 | 88.73 | 218.12 | 145.39 | 74.51 | Upgrade
|
| EBIT Margin | 3.98% | 7.15% | 14.61% | 9.09% | 6.20% | Upgrade
|
| Effective Tax Rate | 8.37% | 12.73% | 16.34% | 16.07% | 9.71% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.